Campbell Deegan Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$449K Buy
374
+3
+0.8% +$3.06K 0.32% 28
2026
Q1
$341K Buy
371
+75
+25% +$76K 0.27% 31
2025
Q4
$318K Buy
296
+13
+5% +$12.4K 0.26% 30
2025
Q3
$216K Hold
283
0.19% 41
2025
Q2
$221K Hold
283
0.22% 41
2025
Q1
$234K Sell
283
-5
-2% -$4.16K 0.27% 37
2024
Q4
$222K Buy
+288
New +$238K 0.27% 39

Other funds holding LLY

Campbell Deegan Wealth Management's LLY Position: Q2 2026 in Review

Campbell Deegan Wealth Management increased its Eli Lilly (LLY) stake by 0.81% in Q2 2026, buying an estimated $3.06K and bringing the position to 374 shares worth $449K. The position accounts for 0.32% of the portfolio, ranked #28.

Campbell Deegan Wealth Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Campbell Deegan Wealth Management held 374 shares of Eli Lilly worth $449K as of Q2 2026.
  • Campbell Deegan Wealth Management bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.32% of Campbell Deegan Wealth Management's portfolio in Q2 2026, its #28 holding.
  • Campbell Deegan Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Campbell Deegan Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.